To be honest, I get very frustrated when the wealth of information presented on this board about dozens of biotechs with novel drugs is bypassed systematically in favour of cheap, sub-$2 biotechs with years of demonstrable failure in the clinic.
In light of that, I think we both know that there is nothing I could say to you to convince you otherwise re: AGEN.
Market Data 
Markets 
AI
